Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.
about
Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adultsDevelopment of Liposomal Ciprofloxacin to Treat Lung InfectionsVaccination against respiratory Pseudomonas aeruginosa infectionA novel microbiota stratification system predicts future exacerbations in bronchiectasisMatrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasisInhaled Antibiotics for Gram-Negative Respiratory InfectionsThe EMBARC European Bronchiectasis Registry: protocol for an international observational studyBronchiectasis and Aspergillus: How are they linked?Polymicrobial airway bacterial communities in adult bronchiectasis patients.Bronchiectasis in Children: Current Concepts in Immunology and MicrobiologyInhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.Children with chronic suppurative lung disease have a reduced capacity to synthesize interferon-gamma in vitro in response to non-typeable Haemophilus influenzae.Non-cystic fibrosis bronchiectasis.Three clinically distinct chronic pediatric airway infections share a common core microbiotaMacrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation.Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis.Effect of airway Pseudomonas aeruginosa isolation and infection on steady-state bronchiectasis in Guangzhou, China.High Pulmonary Levels of IL-6 and IL-1β in Children with Chronic Suppurative Lung Disease Are Associated with Low Systemic IFN-γ Production in Response to Non-Typeable Haemophilus influenzae.Increased Peripheral Blood Pro-Inflammatory/Cytotoxic Lymphocytes in Children with BronchiectasisImpacts of Co-Existing Chronic Rhinosinusitis on Disease Severity and Risks of Exacerbations in Chinese Adults with BronchiectasisDiagnosis of acute kidney injury and its association with in-hospital mortality in patients with infective exacerbations of bronchiectasis: cohort study from a UK nationwide database.A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults.Corticosteroids for severe CAP: the pros.Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis BronchiectasisDistribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review.Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomGlobal impact of bronchiectasis and cystic fibrosis.The bronchiectasis severity index. An international derivation and validation study.To investigate the prevention of OM-85 on bronchiectasis exacerbations (iPROBE) in Chinese patients: study protocol for a randomized controlled trial.Bronchiectasis: an update on current pharmacotherapy and future perspectives.Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.Defining severity in non-cystic fibrosis bronchiectasis.Antimicrobial treatment of non-cystic fibrosis bronchiectasis.Developing drug therapies in bronchiectasis.Challenges in the development of new therapies for bronchiectasis.Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives.An update on pediatric bronchiectasis.Pediatric bronchiectasis: No longer an orphan disease.
P2860
Q24187890-6F926C81-F445-4A99-A6BF-C547DD388B55Q26764772-01113307-31D6-4B7F-9DAD-8A70CFC72EA0Q26824014-18D05EA9-EE68-4FAD-80E5-9D424A0A8D03Q28235177-AFE5443C-C3EC-4B74-8AE6-DCCED01B4CF1Q28256930-A9560CA0-C1CD-41AF-9347-C6BE70348399Q28386160-5B88F28D-35DD-4514-8078-DF9ABCBF3A68Q28596688-9FF13DDB-0465-498C-A354-16B037F9383EQ30243947-DC0DF563-0C9B-4471-9366-50AB016008F2Q33650443-87AD333C-386C-4F75-82FF-A3FE5A3648BEQ33734772-11FAE45E-FFD4-4871-8F5A-F0441E026F2AQ33901651-BE82AB38-ADFD-4185-96A7-8F377C9C62CEQ34027533-C501EA9E-CE48-469E-B68E-526645CE3CE2Q34360714-9D989F6A-F31F-49C6-B916-D5FFADD7AA56Q34425654-F24A7BA6-A039-46A0-9CBE-819E5913A83CQ35112805-7BE08A3E-EF37-4FBC-A498-5D79AEAAC3ADQ35231255-291CFEDE-5D99-4BB5-A1B6-7897BBC2DD5AQ35426622-F707468E-9416-4DB3-A9DA-0CDC47325F2CQ35568350-908B16D7-2567-4309-9051-31DDBE6B7550Q35661067-925A04E0-3713-463F-8099-C08CA535B69EQ35741439-128543C6-E41A-43E0-8F84-E490289D7900Q35764823-EB6306A4-3790-4514-98A7-CC3382A23F0FQ35898514-D520ADBA-F9AD-4BC3-84CB-139DDE4D5DFCQ36015061-1C81BDA8-6F9B-48D8-A0E2-3B52566E49A5Q36116778-C11EED3F-8DC7-4370-8CA5-DD1B21FC7CC6Q36447114-3B12788B-8AAD-497D-82FE-C12B8D02DAC5Q36531859-C13623A3-BEB2-4DFE-AD32-3245D5C0AFA7Q37072994-8778D9BF-0E2D-435C-B97E-F50F21CFE46CQ37354928-658BB173-9FAA-4457-83FD-A92EFEA886CFQ37631978-BB275DB5-EF22-46B7-9BCF-755B4A2E718FQ37688482-95AF9F4D-33F8-480A-911F-7997F0428B42Q37734648-64A5406A-E1B5-4339-A501-FEAD1E08EFCCQ38177329-AE70E23C-D407-455F-8A59-403698E14B0FQ38177909-E4383A29-2DCC-4A98-968C-96763BA12A0CQ38193861-5658174D-E645-4F29-A058-54F50FACEBC1Q38243206-75C7549D-DE0C-41BF-9E6F-1BFBC41F959BQ38259329-915D5062-F765-4B73-B999-C28A4B4B8C8FQ38387657-93654ECF-DB37-43F0-B412-64F4D023C1B6Q38569772-DDE0558E-47EB-4DFB-A16F-48DD1ABA14D9Q38679480-14A287E8-C4E4-4355-A8F7-B19DDBEF0877Q38721361-615380B4-8425-4462-8D34-EC63EFF3916A
P2860
Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Short- and long-term antibioti ...... ystic fibrosis bronchiectasis.
@en
Short- and long-term antibioti ...... ystic fibrosis bronchiectasis.
@nl
type
label
Short- and long-term antibioti ...... ystic fibrosis bronchiectasis.
@en
Short- and long-term antibioti ...... ystic fibrosis bronchiectasis.
@nl
prefLabel
Short- and long-term antibioti ...... ystic fibrosis bronchiectasis.
@en
Short- and long-term antibioti ...... ystic fibrosis bronchiectasis.
@nl
P2093
P2860
P1476
Short- and long-term antibioti ...... ystic fibrosis bronchiectasis.
@en
P2093
Adam T Hill
Cathy Doherty
James D Chalmers
John R Govan
Maeve P Smith
P2860
P304
P356
10.1164/RCCM.201203-0487OC
P407
P577
2012-06-28T00:00:00Z